Inventor · disambiguated record
Raffaella Sordella
Also filed as: SORDELLA RAFFAELLA
13 granted patents·1 pending application·487 citations·filing 2005–2022
93Inventor score
Files withGEN HOSPITAL CORP3MASSACHUSETTS GEN HOSPITAL3BELL DAPHNE WINIFRED2WYETH LLC2COLD SPRING HARBOR LAB1
Top patents by PatentIndex Score
14 records- 0198US7964349B2Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatmentsGEN HOSPITAL CORP·Filed 2007·Granted Jun 21, 2011·92 cites·31 claims
- 0298US7294468B2Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatmentsGEN HOSPITAL CORP·Filed 2005·Granted Nov 13, 2007·187 cites·8 claims
- 0396US8465916B2Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatmentsBELL DAPHNE WINIFRED·Filed 2007·Granted Jun 18, 2013·85 cites·21 claims
- 0496US8105769B2Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatmentsBELL DAPHNE WINIFRED·Filed 2007·Granted Jan 31, 2012·97 cites·4 claims
- 0589US9035036B2Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatmentsGEN HOSPITAL CORP·Filed 2013·Granted May 19, 2015·8 cites·26 claims
- 0686US7947653B1Methods for treating epidermal growth factor receptor tyrosine kinase inhibitor-resistant cancersCOLD SPRING HARBOR LAB·Filed 2011·Granted May 24, 2011·10 cites·8 claims
- 0780US10596162B2Method for treating gefitinib resistant cancerWYETH LLC·Filed 2016·Granted Mar 24, 2020·3 cites·4 claims
- 0875US12006555B2Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatmentsMASSACHUSETTS GEN HOSPITAL·Filed 2020·Granted Jun 11, 2024·0 cites·16 claims
- 0974US10603314B2Method for treating gefitinib resistant cancerHABER DANIEL A·Filed 2006·Granted Mar 31, 2020·3 cites·9 claims
- 1073US10669589B2Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatmentsMASSACHUSETTS GEN HOSPITAL·Filed 2018·Granted Jun 2, 2020·0 cites·13 claims
- 1171US2023226039A1Method for treating gefitinib resistant cancerWYETH LLC·Filed 2022·Application pending·0 cites
- 1262US8323883B1Methods of assessing therapeutic benefits of patients having cancers resistant to epidermal growth factor receptor kinase inhibitorsSORDELLA RAFFAELLA·Filed 2010·Granted Dec 4, 2012·2 cites·7 claims
- 1359US10000815B2Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatmentsMASSACHUSETTS GEN HOSPITAL·Filed 2015·Granted Jun 19, 2018·0 cites·32 claims
- 1428US10501741B2Methods and compositions for inhibiting growth and epithelial to mesenchymal transition (EMT) in cancer cellsCOLD SPRING HARBOR LABORATORY·Filed 2015·Granted Dec 10, 2019·0 cites·25 claims
Join the waitlist — get patent alerts
Get an alert when Raffaella Sordella files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →